Guardant Health
325 hedge funds and large institutions have $6.85B invested in Guardant Health in 2020 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 141 increasing their positions, 64 reducing their positions, and 32 closing their positions.
122% more first-time investments, than exits
New positions opened: 71 | Existing positions closed: 32
120% more repeat investments, than reductions
Existing positions increased: 141 | Existing positions reduced: 64
25% more capital invested
Capital invested by funds: $5.46B → $6.85B (+$1.39B)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
13% more funds holding
Funds holding: 288 → 325 (+37)
2.79% more ownership
Funds ownership: 83.12% → 85.91% (+2.8%)
52% less call options, than puts
Call options by funds: $26.8M | Put options by funds: $55.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$173M |
| 2 |
BlackRock
New York
|
+$125M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
+$115M |
| 4 |
Morgan Stanley
New York
|
+$77.6M |
| 5 |
FAM
Fred Alger Management
New York
|
+$71.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$718M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$58.8M |
| 3 |
Coatue Management
New York
|
-$57.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$29.9M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$29.1M |
GH Hedge Fund Activity: Q2 2020 in Review
325 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q2 2020, worth a combined $6.85B — up 25% from $5.46B a quarter earlier.
Buyers outnumbered sellers: 71 funds opened new GH positions and 32 closed out — a net gain of 39 holders — while 141 added to existing stakes and 64 trimmed.
The largest buyer was Vanguard Group, adding an estimated $173M. The largest seller was SB Investment Advisers (UK), cutting an estimated $718M.
- 325 institutional investors held Guardant Health (GH) as of Q2 2020, up from 288 in Q1 2020.
- Funds reported $6.85B of Guardant Health stock for Q2 2020, up 25% quarter-over-quarter.
- 71 funds opened new Guardant Health positions in Q2 2020 and 32 closed out, a net change of +39 holders.
- The largest Guardant Health buyer in Q2 2020 was Vanguard Group, an estimated $173M added.
- The largest Guardant Health seller in Q2 2020 was SB Investment Advisers (UK), an estimated $718M sold.
Based on aggregated 13F filings for Q2 2020.